Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Medtronic
Boehringer Ingelheim
Merck
Johnson and Johnson
Dow

Last Updated: December 6, 2019

DrugPatentWatch Database Preview

Litigation Details for Bayer Schering Pharma AG v. Sandoz, Inc. (S.D.N.Y. 2008)

See Plans and Pricing

« Back to Dashboard

Bayer Schering Pharma AG v. Sandoz, Inc. (S.D.N.Y. 2008)

Docket   Start Trial Date Filed 2008-09-18
Court District Court, S.D. New York Date Terminated 2012-09-30
Cause 28:1338pt Patent Infringement Assigned To Paul G. Gardephe
Jury Demand Plaintiff Referred To Magistrate Judge James C. Fran
Parties BAYER HEALTHCARE PHARMACEUTICALS INC; BAYER SCHERING PHARMA AG; SANDOZ, INC.; WATSON LABORATORIES, INC.; WATSON PHARMACEUTICALS, INC.
Patents 5,569,652; 6,787,531; 6,933,395
Attorneys Adam K. Mortara; Bradford J. Badke; Cedric Chia Yang Tan; Jeanne C. Curtis; Joseph A. Hynds; Kristen Marie Cooklin; Lisa N. Phillips; Mark T. Jansen; Matthew A. Traupman; Matthew Raymond Ford; Nancy Lynn Tompkins; Paul J. Skiermont; Peter Benjamin Bensinger , Jr.; Phillip A. Proger; Ronald William Meister; Steven Jerome Moore; Sundeep K. Addy; Thomas Kjellberg
Firms Bartlit Beck Herman Palenchar & Scott LLP (IL)
Link to Docket External link to docket
Small Molecule Drugs cited in Bayer Schering Pharma AG v. Sandoz, Inc.
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial , and   Start Trial .

Details for Bayer Schering Pharma AG v. Sandoz, Inc. (S.D.N.Y. 2008)

Date Filed Document No. Description Snippet Link To Document
2008-09-18 1 thereto. PATENT-IN-SUIT 24. The patent-in-suit is United States Patent No. 5,569,652 (“the ‘652 patent”) (… Umted States Patent nn nn Patent Number: 5,569,652 Beier et al. [45] Date of Patent: Oct. 29, 1996 … CoUNT 0an CLAIM FoR PATENT INFRINGEMENT OF UNITED STATES PATENT No. 5,569,652 AGAINST SANDoz, INC. UNDER… CoUNT Two: CLAIM FoR PATENT INFRINGEMENT OF UNITED STATES PATENT No. 5,569,652 AGAINST SANDoz, INC. UNDER…CoUNT THREE: CLAIM FoR PATENT INFanGEiirENT OF UNITED STATES PATENT No. 5,569,652 AGAINST WA'rsoN UNDER External link to document
2010-10-26 97 Covenant Not to Sue Sandoz Regarding U.S. Patent Nos. 6,787,531 and 6,933,395. Document filed by Bayer Healthcare… 30 September 2012 1:08-cv-08112 830 Patent Plaintiff District Court, S.D External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Dow
Colorcon
AstraZeneca
Johnson and Johnson
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.